scholarly article | Q13442814 |
P356 | DOI | 10.1158/0008-5472.CAN-05-0961 |
P698 | PubMed publication ID | 16204068 |
P50 | author | Ultan McDermott | Q39992201 |
Wendy L Allen | Q56056799 | ||
P2093 | author name string | Patrick G Johnston | |
Daniel B Longley | |||
Leeona Galligan | |||
Timothy Wilson | |||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colorectal cancer | Q188874 |
P304 | page(s) | 8951-8960 | |
P577 | publication date | 2005-10-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer | |
P478 | volume | 65 |
Q39530180 | Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3. |
Q46634635 | Altered gene expression in rat colonic adenocarcinomas induced in an azoxymethane plus 2-amino-1-methyl-6-phenylimidazo[4,5-b]- pyridine initiation-promotion model |
Q89003018 | C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer |
Q39803115 | Camptothecin induces apoptosis of human retinoblastoma cells via activation of FOXO1. |
Q39407582 | Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer |
Q34547088 | Crude extract of Rheum palmatum L induced cell death in LS1034 human colon cancer cells acts through the caspase-dependent and -independent pathways |
Q36588920 | Delivery of intracellular-acting biologics in pro-apoptotic therapies |
Q37666015 | Emerging roles of p53 and other tumour-suppressor genes in immune regulation |
Q39903499 | Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells |
Q40054238 | Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents |
Q36084498 | Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis |
Q43950442 | Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer |
Q39937932 | In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer. |
Q37571729 | Irinotecan therapy and molecular targets in colorectal cancer: a systemic review |
Q93023701 | Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer |
Q35955331 | Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer. |
Q36193189 | Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cells. |
Q64884447 | Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells. |
Q80455307 | STAT1 activation in squamous cell cancer of the oral cavity: a potential predictive marker of response to adjuvant chemotherapy |
Q37177918 | TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy |
Q38846369 | Upregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis |
Search more.